This site is intended for Healthcare Professionals only.

UK Covid-19 prevalence up due to Delta not Omicron

Date:

Share post:

The prevalence of Covid-19 infections in England rose to around one in 60 people in the week ending November 27, the Office for National Statistics said today (December 03), led higher by the dominant Delta variant rather than the newly identified Omicron.

The prevalence was up from one in 65 reported the previous week, the ONS said, adding that 99 per cent of all coronavirus infections which were sequenced were genetically compatible with the Delta variant.

“To date, we have not identified any infections compatible with the new Omicron variant (B.1.1.529) among our survey participants,” the ONS said.

Prime Minister Boris Johnson has introduced travel restrictions and some mask mandates, with a view to slowing the spread of Omicron while work is undertaken to understand it better.

There have been 42 confirmed cases of the variant in Britain, which has mutations consistent with reduced vaccine efficacy.

But it is the spread of the dominant and highly transmissible Delta variant, especially among children, that is keeping infection levels high. On Thursday, Britain reported its highest daily infection number since July.

The ONS said that infections had increased in younger children, with 4.25 per cent estimated to be infected, and remained high in older children, where 3.46 per cent were estimated to be infected.

Ravi Gupta, professor of clinical microbiology, University of Cambridge, said that it was not a given that Omicron would entirely displace Delta, which might continue to circulate in unvaccinated populations like young children.

“More Delta circulating in kids and then more Omicron circulating proportionately in vaccinated individuals is one scenario that could play out… it will be hard to displace Delta completely,” he told Reuters.

Omicron is not spreading rapidly at the moment, by the look of it… there is probably sustained community transmission, but it’s probably just starting.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

PDA opposes DiCE guidance on online prescribing for GLP-1 agonist

PDA has withheld its endorsement of the DiCE guidance due to concerns over patient safety The Pharmacist's Defence Association...

Locum Pharmacist acquires 30-hour Moorside Pharmacy

The new owner plans to run Moorside Pharmacy on a hands-on basis and introduce additional services for the...

Breakthrough: Cabotegravir shows 88% reduction in HIV-1 incidence

Recommended by NICE and approved by the MHRA, Cabotegravir 600 mg long-acting injection is the first injectable treatment...

Why Community Pharmacy Must Embrace Innovation? Insights from Pharmacists

Future of community pharmacy: Pharmacists highlight the significance of embracing innovation and collaboration to improve efficiency and patient...